DUBLIN, Sept. 6, 2023 /PRNewswire/ — In light of the recent European Medicines Agency’s safety committee recommendation against the use of topiramate-containing medicines in pregnant women, the importance of rigorous pharmacovigilance practices has never been more evident. The…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.